| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ONCT | Oncternal Therapeutics, Inc. | AKER HAZEL M | Legal Counsel | Jul 21, 2020 | Buy | $2.38 | 41,972 | 99,998 | 46,987 | Jul 23, 2020, 05:00 PM | |
| CADX | CADENCE PHARMACEUTICALS INC | AKER HAZEL M | SVP, GC & Secretary | Mar 19, 2014 | Option Exercise | $14.00 | 3,745 | 52,430 | 0 | Mar 21, 2014, 01:20 PM | |
| CADX | CADENCE PHARMACEUTICALS INC | AKER HAZEL M | SVP, GC & Secretary | Dec 16, 2013 | Sale | $6.14 | 26,028 | 159,682 | 16,759 | Dec 18, 2013, 04:22 PM | |
| CADX | CADENCE PHARMACEUTICALS INC | AKER HAZEL M | SVP, GC & Secretary | Nov 15, 2013 | Sale | $5.46 | 104,112 | 568,191 | 55,801 | Nov 18, 2013, 06:36 PM | |
| CADX | CADENCE PHARMACEUTICALS INC | AKER HAZEL M | SVP, GC & Secretary | Jul 22, 2013 | Option Exercise | $5.66 | 13,014 | 73,659 | 10,252 | Jul 23, 2013, 06:59 PM | |
| CADX | CADENCE PHARMACEUTICALS INC | AKER HAZEL M | SVP, GC & Secretary | Jul 15, 2013 | Sale | $5.43 | 13,016 | 70,623 | 10,253 | Jul 17, 2013, 04:23 PM | |
| CADX | CADENCE PHARMACEUTICALS INC | AKER HAZEL M | SVP, GC & Secretary | Nov 21, 2011 | Sale | $4.16 | 10,000 | 41,621 | 3,745 | Nov 22, 2011, 06:23 PM |
Menu